Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gellermann
Carsten Gellermann, Gerbrunn DE
| Patent application number | Description | Published |
|---|---|---|
| 20080314286 | Reactive Particles, Production Thereof, and Use Thereof in Kits and Cements - Ionomer particles with an inner area and an outer area are provided. The outer area has an oxidic matrix with cations selected by observing the following conditions. Only two different types of cations must be present that belong to one of the following groups (a) to (d), and these two types of cations must be selected from two different ones of the groups (a) to (d): (a) ions of the elements of the second main group and bivalent ions of the transition elements and the lanthanides; (b) ions of the elements of the third main group with the exception of boron and trivalent ions of the transition elements and the lanthanides; (c) ions of the elements of the fourth main group with exception of carbon and tetravalent ions of the transition elements and the lanthanides (d) ions of the elements of the fifth main group, selected from ions of antimony and bismuth and pentavalent ions of the transition elements. Particles of the composition ZrO | 12-25-2008 |
| 20080317794 | Agglomerate Particles, Method for Producing Nanocomposites, and the Use Thereof - The invention relates to agglomerate particles which are constructed from agglomerated nanoscale primary particles and also to a method for incorporation of these particles in a polymer matrix and to the use of these agglomerate particles. | 12-25-2008 |
Gerald Gellermann, Mannheim DE
| Patent application number | Description | Published |
|---|---|---|
| 20100173828 | A (X - 38 .. 43) oligomers, and processes, compositions, and uses thereof - The present invention relates to an Aβ(X-38 . . . 43) oligomer having a high molecular weight, or a derivative thereof, a process for preparing the oligomer or derivative, compositions comprising the oligomer or derivative, and uses of the oligomer or derivative such as its use for treating or preventing an amyloidosis (e.g. by active immunization), for diagnosing an amyloidosis, and for providing agents that are capable of binding to the Aβ(X-38 . . . 43) oligomer or derivative. The subject invention also describes agents that are capable of binding to the Aβ(X-38 . . . 43) oligomer or derivative, e.g. antibodies, compositions comprising the agents, and uses of the agents such as their use for treating or preventing an amyloidosis (e.g. by passive immunization) and for diagnosing an amyloidosis. | 07-08-2010 |
Werner Gellermann, Salt Lake City, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20090244484 | SYSTEMS AND METHODS FOR OPTICAL DETECTION OF LIPOFUSCIN CONCENTRATIONS IN A SUBJECT'S EYE - A method for optical detection of lipofuscin concentrations in the retina is described. A subject's eye is exposed to a light source. Light emitted from the subject's eye is detected. Levels of lipofuscin are determined from the emitted light. A system for optical detection of lipofuscin in the retina is described. The system includes a light source to generate light. The system includes an optical detector in optical communication with the light source. The optical detector is configured to detect light emitted from a subject's eye. A computing device in electronic communication with the optical detector is included in the system to determine levels of lipofuscin from the emitted light. | 10-01-2009 |
| 20100179435 | NONINVASIVE MEASUREMENT OF FLAVONOID COMPOUNDS IN BIOLOGICAL TISSUE - Methods and apparatus are disclosed which facilitate the rapid, noninvasive and quantitative measurement of the concentration of flavonoid compounds, as well as their isomers and metabolites, in biological tissue such as human skin. Low-intensity, visible-light illumination of intact tissue provides for high spatial resolution, and allows for precise quantification of the flavonoid levels in the tissue. The preferred embodiments malce use of a previously unknown, low-oscillator strength, optical absorption transition of flavonoids. This malces it possible to optically excite flavonoids in living human tissue outside the absorption range of other, potentially confounding skin chromophores. A system constructed in accordance with the invention includes a source of light for illuminating a localized region of tissue with light that overlaps the absorption bands of a flavonoid compound; a device for detecting the fluorescence emitted by the flavonoid compound resulting from the illumination; and a processor for determining the concentration level of the flavonoid compound based upon the detected fluorescence. | 07-15-2010 |